We use cookies to enhance your experience. If you continue browsing, it means you agree to our use of these cookies. For detailed information on how we use cookies, please refer to our cookie policy.
Accept All Reject
On August 19, 2025, the Signing Ceremony for the Cooperative Development and Achievements Commercialization Agreemen tbetween Shanghai Institute of Biomedical and Pharmaceutical Technologies and Au...
Aurisco Pharmaceutical today announced that its manufacturing site in Badu, Tiantai has successfully passed a USFDA cGMP inspection, which lasted for 5 days , from March 17 to March 21,2025. Th...
On September 21, 2020, Aurisco Pharmaceutical Co., Ltd. (Stock code: 605116) was officially listed on the Shanghai Stock Exchange. The per share issuing price is RMB 8.37 yuan, number of shares iss...